cetirizine has been researched along with Alopecia in 10 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
Alopecia: Absence of hair from areas where it is normally present.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cetirizine, a widely used agent for allergic disorders, has recently been topically used for treating androgenetic alopecia (AGA)." | 10.60 | Topical cetirizine for treating androgenetic alopecia: A systematic review. ( Chen, X; Xiang, H; Yang, M, 2022) |
| " In the present study, the efficacy and safety of twice daily application of topical cetirizine 1% versus minoxidil 5% solutions for 16 weeks were compared in male androgenetic alopecia (AGA)." | 9.41 | Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study. ( Firooz, A; Guishard, A; Hossein Mostafa, D; Nasrollahi, SA; Niknam, S; Samadi, A, 2021) |
| "Levocetirizine hydrochloride (LVC) is an antihistaminic drug that is repurposed for the treatment of alopecia." | 8.12 | Repurposing levocetirizine hydrochloride loaded into cationic ceramide/phospholipid composite (CCPCs) for management of alopecia: central composite design optimization, ( Alahdal, AM; Albash, R; Darwish, KM; El-Dahmy, RM; Fahmy, AM; Hamed, MIA; Kassem, AB, 2022) |
| "We report the case of a 70-year-old woman affected by breast cancer in treatment with Palbociclib, who developed alopecia." | 8.02 | A new treatment of alopecia induced by palbociclib: Topical cetirizine. ( Carlesimo, M; Caro, G; Federico, A; Fortuna, MC; Magri, F; Rossi, A, 2021) |
| "Cetirizine is an antihistamine that may be effective in hair loss treatment." | 7.30 | Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study. ( Abbassi, MM; Bassiouny, EA; El-Samanoudy, SI; Farid, SF; Nada, HR, 2023) |
| "Cetirizine, a widely used agent for allergic disorders, has recently been topically used for treating androgenetic alopecia (AGA)." | 6.60 | Topical cetirizine for treating androgenetic alopecia: A systematic review. ( Chen, X; Xiang, H; Yang, M, 2022) |
| " In the present study, the efficacy and safety of twice daily application of topical cetirizine 1% versus minoxidil 5% solutions for 16 weeks were compared in male androgenetic alopecia (AGA)." | 5.41 | Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study. ( Firooz, A; Guishard, A; Hossein Mostafa, D; Nasrollahi, SA; Niknam, S; Samadi, A, 2021) |
| "Levocetirizine hydrochloride (LVC) is an antihistaminic drug that is repurposed for the treatment of alopecia." | 4.12 | Repurposing levocetirizine hydrochloride loaded into cationic ceramide/phospholipid composite (CCPCs) for management of alopecia: central composite design optimization, ( Alahdal, AM; Albash, R; Darwish, KM; El-Dahmy, RM; Fahmy, AM; Hamed, MIA; Kassem, AB, 2022) |
| "We report the case of a 70-year-old woman affected by breast cancer in treatment with Palbociclib, who developed alopecia." | 4.02 | A new treatment of alopecia induced by palbociclib: Topical cetirizine. ( Carlesimo, M; Caro, G; Federico, A; Fortuna, MC; Magri, F; Rossi, A, 2021) |
| "Cetirizine is an antihistamine that may be effective in hair loss treatment." | 3.30 | Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study. ( Abbassi, MM; Bassiouny, EA; El-Samanoudy, SI; Farid, SF; Nada, HR, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 7 (70.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X | 1 |
| Xiang, H | 1 |
| Yang, M | 1 |
| Albash, R | 1 |
| El-Dahmy, RM | 1 |
| Hamed, MIA | 1 |
| Darwish, KM | 1 |
| Alahdal, AM | 1 |
| Kassem, AB | 1 |
| Fahmy, AM | 1 |
| Bassiouny, EA | 1 |
| El-Samanoudy, SI | 1 |
| Abbassi, MM | 1 |
| Nada, HR | 1 |
| Farid, SF | 1 |
| Wen, S | 1 |
| Wei, J | 1 |
| Bao, J | 1 |
| Guo, T | 1 |
| Zheng, W | 1 |
| Zhuang, X | 1 |
| Lin, Y | 1 |
| Caro, G | 1 |
| Fortuna, MC | 2 |
| Magri, F | 1 |
| Federico, A | 1 |
| Carlesimo, M | 2 |
| Rossi, A | 2 |
| Zaky, MS | 1 |
| Abo Khodeir, H | 1 |
| Ahmed, HA | 1 |
| Elsaie, ML | 1 |
| Hossein Mostafa, D | 1 |
| Samadi, A | 1 |
| Niknam, S | 1 |
| Nasrollahi, SA | 1 |
| Guishard, A | 1 |
| Firooz, A | 1 |
| Campo, D | 1 |
| Garelli, V | 1 |
| Pranteda, G | 1 |
| De Vita, G | 1 |
| Sorriso-Valvo, L | 1 |
| Di Nunno, D | 1 |
| Mardones, F | 1 |
| Shapiro, J | 1 |
| Abdelmaksoud, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Topical Cetirizine Versus Topical Betamethasone in Treatment of Localized Alopecia Areata[NCT05803070] | 59 participants (Anticipated) | Observational | 2023-09-01 | Not yet recruiting | |||
| The Role of Cetirizine in Androgenetic Alopecia in Females[NCT04481412] | Phase 2/Phase 3 | 66 participants (Actual) | Interventional | 2020-07-25 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for cetirizine and Alopecia
| Article | Year |
|---|---|
Topical cetirizine for treating androgenetic alopecia: A systematic review.
Topics: Administration, Topical; Alopecia; Cetirizine; Hair; Humans; Minoxidil; Treatment Outcome | 2022 |
4 trials available for cetirizine and Alopecia
| Article | Year |
|---|---|
Topical cetirizine for treating androgenetic alopecia: A systematic review.
Topics: Administration, Topical; Alopecia; Cetirizine; Hair; Humans; Minoxidil; Treatment Outcome | 2022 |
Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study.
Topics: Administration, Topical; Alopecia; Cetirizine; Drug-Related Side Effects and Adverse Reactions; Fema | 2023 |
Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study.
Topics: Administration, Topical; Adult; Alopecia; Cetirizine; Histamine Antagonists; Humans; Male; Minoxidil | 2021 |
A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia.
Topics: Administration, Topical; Adult; Aged; Alopecia; Cetirizine; Female; Histamine H1 Antagonists, Non-Se | 2018 |
A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia.
Topics: Administration, Topical; Adult; Aged; Alopecia; Cetirizine; Female; Histamine H1 Antagonists, Non-Se | 2018 |
A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia.
Topics: Administration, Topical; Adult; Aged; Alopecia; Cetirizine; Female; Histamine H1 Antagonists, Non-Se | 2018 |
A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia.
Topics: Administration, Topical; Adult; Aged; Alopecia; Cetirizine; Female; Histamine H1 Antagonists, Non-Se | 2018 |
6 other studies available for cetirizine and Alopecia
| Article | Year |
|---|---|
Repurposing levocetirizine hydrochloride loaded into cationic ceramide/phospholipid composite (CCPCs) for management of alopecia: central composite design optimization,
Topics: Alopecia; Ceramides; Cetirizine; Drug Carriers; Drug Repositioning; Humans; Particle Size; Phospholi | 2022 |
Effect of levocetirizine hydrochloride on the growth of human dermal papilla cells: a preliminary study.
Topics: Alopecia; Cell Proliferation; Cells, Cultured; Cetirizine; Female; Hair Follicle; Histamine H1 Antag | 2020 |
A new treatment of alopecia induced by palbociclib: Topical cetirizine.
Topics: Administration, Topical; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Cetirizine; Cyclin | 2021 |
Therapeutic implications of topical cetirizine 1% in treatment of male androgenetic alopecia: A case-controlled study.
Topics: Administration, Topical; Adult; Alopecia; Cetirizine; Hair; Humans; Male; Middle Aged; Minoxidil; Yo | 2021 |
Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience.
Topics: Administration, Topical; Adult; Age of Onset; Alopecia; Cetirizine; Chile; Clobetasol; Drug Therapy, | 2017 |
Topical cetirizine 1% for treatment of androgenetic alopecia.
Topics: Administration, Topical; Alopecia; Cetirizine; Hair; Humans; Minoxidil | 2017 |